No Change in Empagliflozin Effect with Metformin

被引：0
|
作者：
Franke, Katharina
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2016年 / 11卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：211 / 211
页数：1
相关论文
共 50 条
  • [41] Inherent stability testing of empagliflozin in the presence of metformin HCl by HPTLC and characterization of degradation products of empagliflozin by LC-ESI-QTOF-MS/MS
    Vichare, Vijaya
    Choudhari, Vishnu
    Tambe, Vrushali
    Dhole, Shashikant
    JPC-JOURNAL OF PLANAR CHROMATOGRAPHY-MODERN TLC, 2022, 35 (01) : 61 - 71
  • [42] Cost-effectiveness of Empagliflozin, in Addition to Metformin, in Patients with Type 2 Diabetes in Italy
    Mannucci, Edoardo
    Ghetti, Gianni
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2022, 23 (01) : 85 - 95
  • [43] No Significant Change of Glucagon Level by Empagliflozin in Diabetic Mice
    Shimoda, Hiromi
    Seino, Yusuke
    Himeno, Tatsuhito
    Inoue, Rieko
    Motegi, Mikio
    Hayami, Tomohide
    Asano, Emi
    Asano, Saeko
    Kato, Makoto
    Yamada, Yuichiro
    Miura-Yura, Emiri
    Kondo, Masaki
    Tsunekawa, Shin
    Kato, Yoshiro
    Kato, Koichi
    Hayashi, Yoshitaka
    Nakamura, Jiro
    Kamiya, Hideki
    DIABETES, 2019, 68
  • [44] Resolving Problems Encountered in Spectrophotometric Analysis of a Ternary Mixture of Linagliptin, Empagliflozin and Metformin Hydrochloride
    Elagamy, Samar H.
    ANALYTICAL CHEMISTRY LETTERS, 2022, 12 (03) : 349 - 357
  • [45] Therapy of empagliflozin plus metformin on T2DM mice shows no higher amelioration for glucose and lipid metabolism than empagliflozin monotherapy
    Wang, Zhiguo
    Zhou, Ji
    Lu, Mengran
    Liang, Yuwan
    Jiang, Zhengxuan
    Chen, Keyang
    LIFE SCIENCES, 2019, 232
  • [46] Comparative Study of Different Derivative Spectrophotometric Techniques for the Analysis and Separation of Metformin, Empagliflozin, and Glimepiride
    Amin, Khanda F. M.
    Fakhre, Nabil A.
    Abdullah, Ahmed M.
    CURRENT PHARMACEUTICAL ANALYSIS, 2020, 16 (07) : 916 - 934
  • [47] Effect of empagliflozin compared with glimepiride as add-on to metformin for 2 years on the amount and distribution of body fat in patients with type 2 diabetes
    Kim, G.
    Ridderstrale, M.
    Andersen, K. R.
    Zeller, C.
    Woerle, H. J.
    Broedl, U. C.
    DIABETOLOGIA, 2014, 57 : S330 - S331
  • [48] Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study
    Caturano, Alfredo
    Galiero, Raffaele
    Loffredo, Giuseppe
    Vetrano, Erica
    Medicamento, Giulia
    Acierno, Carlo
    Rinaldi, Luca
    Marrone, Aldo
    Salvatore, Teresa
    Monda, Marcellino
    Sardu, Celestino
    Marfella, Raffaele
    Sasso, Ferdinando Carlo
    BIOMEDICINES, 2023, 11 (02)
  • [49] The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome
    Javed, Zeeshan
    Papageorgiou, Maria
    Madden, Leigh A.
    Rigby, Alan S.
    Kilpatrick, Eric S.
    Atkin, Stephen L.
    Sathyapalan, Thozhukat
    ENDOCRINE CONNECTIONS, 2020, 9 (06) : 563 - 569
  • [50] Empagliflozin as Add-on Therapy to Pioglitazone With or Without Metformin in Patients With Type 2 Diabetes Mellitus
    Kovacs, Christopher S.
    Seshiah, Veeraswamy
    Merker, Ludwig
    Christiansen, Anita Vedel
    Roux, Flavien
    Salsali, Afshin
    Kim, Gabriel
    Stella, Peter
    Woerle, Hans-Juergen
    Broedl, Uli C.
    CLINICAL THERAPEUTICS, 2015, 37 (08) : 1773 - 1788
12345